<DOC>
	<DOC>NCT01840254</DOC>
	<brief_summary>The aim of this study is to test the hypothesis that addition of dexmedetomidine to fentanyl-based intravenous patient controlled analgesia (PCA) reduces requirement of fentanyl bolus and consequent postoperative nausea and vomiting in high-risk patients undergoing lumbar spine surgery.</brief_summary>
	<brief_title>Effect of Combination Dexmedetomidine Added to Fentanyl-based Intravenous Patient-controlled Analgesia on Nausea Vomiting in Highly Susceptible Patients Undergoing Lumbar Spinal Surgery: Prospective Double Blinded Randomized Controlled Trial</brief_title>
	<detailed_description />
	<mesh_term>Fentanyl</mesh_term>
	<mesh_term>Dexmedetomidine</mesh_term>
	<criteria>1. female, nonsmoking patient who are 2065 of age scheduled for elective lumbar spine surgery 1. Bradycardia on EKG (45bpm) 2. Atrioventricular conduction disorder 3. Uncontrolled hypertension 4. angina history 5. obesity (BMI â‰¥ 30 kg/m2) 6. Preoperative administration of opioid 7. Preoperative administration of antiemetics 8. Gastrointestinal disorder history 9. Hepatic or renal disease 10. Pregnant 11. Foreigner</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>PONV</keyword>
	<keyword>IV PCA</keyword>
	<keyword>dexmedetomidine</keyword>
	<keyword>Female</keyword>
	<keyword>non-smoking</keyword>
	<keyword>lumbar spine surgery</keyword>
</DOC>